Keep moving forward


Provide high quality drug efficacy testing for unmet medical needs

Central Nervous System





Hamamatsu Pharma Research (HPR) offers translational research innovations through preclinical efficacy evaluation of novel therapeutics in cynomolgus macaque-based disease models. With HPR's pharmacological expertise and unique approach to preclinical research, HPR will help you boost your research to the next level.

Learn more about us.

Ideal Preclinical Model Species

Because of the genetic closeness of nonhuman primate to humans, HPR's cynomolgus macaque-based models will add significant value to your preclinical findings.  

Learn more about NHP

Neuroimaging of Pain

Stimulus evoked brain activation as a quantifiable outcomemeasure obtained with clinical grade noninvasive neuroimaging.

Learn more about our pain evaluation method

HPR News


Please feel free to contact us for more details concerning our NHP models and services

Follow us:

HPR ProudCROMember_Biocom

Copyright © HAMAMATSU PHARMA RESEARCH U.S.A., Inc All rights reserved.

Hamamatsu Pharma Research U.S.A., Inc (Business Development Office)

400 N Tustin Ave. Ste 240 Santa Ana, CA 92705

E-mail: info_us[at]